SCHEMBL7252247

SCHEMBL7252247

COC(=O)Cc1cc(Br)c(Oc2cc(I)c(OC)cc2C(=O)c2cccc(C)c2)c(Br)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.66
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
ABL1 P00519 1/20 0.37
RIN1 Q13671 1/20 0.37
TP53 P04637 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7254627 0.91 NR3C1 (0.78) NR3C1GAAKDM4EALDH1A1CTNNB1
SCHEMBL7256747 0.89 NR3C1 (0.62) NR3C1GAAKDM4EALDH1A1NPC1
SCHEMBL5630623 0.88 NR3C1 (0.85) NR3C1GAAKDM4EALDH1A1NPC1
SCHEMBL7252910 0.88 NR3C1 (0.63) NR3C1GAAKDM4EALDH1A1NPC1
SCHEMBL7547206 0.85 NR3C1 (0.59) NR3C1GAAKDM4EALDH1A1NPC1
SCHEMBL7254157 0.83 NR3C1 (0.57) NR3C1GAAKDM4EALDH1A1NPC1
SCHEMBL5630342 0.82 NR3C1 (0.70) NR3C1THRATHRB
SCHEMBL7054017 0.81 NR3C1 (0.69) NR3C1THRATHRBCYP1A2CYP2C19
SCHEMBL7257439 0.80 NR3C1 (0.73) NR3C1GAAKDM4EALDH1A1TP53
SCHEMBL5632584 0.79 NR3C1 (1.00) NR3C1THRATHRBALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030166725-A1 Compounds active at the glucocorticoid receptor KARO BIO AB (SE) 2003-09-04 US disclosed
EP-1265839-A1 COMPOUNDS ACTIVE AT THE GLUCOCORTICOID RECEPTOR KARO BIO AB (SE) 2002-12-18 EP disclosed
WO-2001047859-A1 COMPOUNDS ACTIVE AT THE GLUCOCORTICOID RECEPTOR KARO BIO AB (SE) 2001-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166725-A1 Compounds active at the glucocorticoid receptor NR3C1, NR3C2, GPR119 NR3C1 1/4885GAA 1258/4885KDM4E 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.